NASDAQ:JAZZ

Jazz Pharmaceuticals Stock News

etoro logo Buy JAZZ
*Your capital is at risk
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
Investors are excited about positive late-stage results for its narcolepsy drug.
Through six seasons, Utah Jazz coach Quin Snyder has had a wide variety of rotation pieces. Here's a look at some of his best and most interesting lineups through the years.
Oregon Public Employees Retirement Fund decreased its position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 7.8% in the first quarter, according to its most recent Form 13F filing with the S
Avadel Pharmaceuticals (NASDAQ:AVDL) jumps 30% premarket on average volume in reaction to positive results from a Phase 3 clinical trial, REST-ON, evaluating lead candidate FT218, a once-nightly for
BidaskClub downgraded shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) from a sell rating to a strong sell rating in a report released on Thursday morning, BidAskClub reports. Other equities analysts have
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – Stock analysts at SVB Leerink cut their FY2020 earnings per share estimates for shares of Jazz Pharmaceuticals in a research report issued to clients and inv
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
SAN DIEGO, April 24, 2020 -- Pfenex Inc. (NYSE American: PFNX) announced today that it will report its financial results for the first quarter ended March 31, 2020, after the.
Jazz Aviation and Air Canada Cargo to be First to Operate Routes with Dash 8-400 Aircraft Simplified Package Freighter Developed by De Havilland Canada
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – Equities research analysts at Piper Sandler issued their Q1 2020 earnings per share estimates for Jazz Pharmaceuticals in a research note issued on Monday, A
With ESPN's The Last Dance documentary on Michael Jordan's Bulls and their final triumph in 1998 over the Utah Jazz, we compared box scores from those Finals to last season's for an idea of how much t
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 2,760,000 shares, a decline of 13.1% fro
Emergent BioSolutions Inc. (EBS) today announced the appointment of Dr. Karen L. Smith, M.D., Ph.D. as chief medical officer with responsibility for leading and further establishing Emergent’s globa
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 first quarter financial results on Tuesday, May 5, 2020, after the close of the financial markets. Company manageme
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE